Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway
Acta Pharmaceutica Sinica B · 2024-10 · 14 (10) · 4461-4477
DOI: 10.1016/j.apsb.2024.07.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-10. Verfasst von Yucheng Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin H…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Education Commission.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is recognized as an aggressive cancer that is characterized by significant metabolic reprogramming. Here, we applied spatial metabolomics to achieve high-throughput, in situ identification of metabolites within the liver metastases of AML mice. Alterations at metabolite and protein levels were further mapped out and validated by integrating untargeted metabolomics and proteomics. This study showed a downregulation in arginine's contribution to polyamine biosynthesis and urea cycle, coupled with an upregulation of the creatine metabolism. The upregulation of creatine synthetases Gatm and Gamt, as well as the creatine transporter Slc6a8, resulted in a marked accumulation of creatine within tumor foci. This process further enhances oxidative phosphorylation and glycolysis of leukemia cells, thereby boosting ATP production to foster proliferation and infiltration. Importantly, we discovered that inhibiting Slc6a8 can counter these detrimental effects, offering a new strategy for treating AML by targeting metabolic pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine…
- College of Osteopathic Medicine, Kansas City University, Kansas City, MO 64106, USA.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug, Beijing 100050, China.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
Zitieren
APA
Bao, Y., Qiao, J., Gong, W., Zhang, R., Zhou, Y., Xie, Y., Xie, Y., He, J., & Yin, T. (2024). Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway. Acta Pharmaceutica Sinica B, 14(10), 4461-4477. https://doi.org/10.1016/j.apsb.2024.07.004
Vancouver
Bao Y, Qiao J, Gong W, Zhang R, Zhou Y, Xie Y, et al. Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway. Acta Pharmaceutica Sinica B. 2024;14(10):4461-4477. doi:10.1016/j.apsb.2024.07.004
BibTeX
@article{Bao2024,
author = {Bao, Yucheng and Qiao, Jing and Gong, Wenjie and Zhang, Ruihong and Zhou, Yanting and Xie, Yinyin and Xie, Yuan and He, Jiuming and Yin, Tong},
title = {Spatial metabolomics highlights metabolic reprogramming in acute myeloid leukemia mice through creatine pathway},
journal = {Acta Pharmaceutica Sinica B},
year = {2024},
volume = {14},
number = {10},
pages = {4461--4477},
doi = {10.1016/j.apsb.2024.07.004}
}
EUVIMED